Articles related to VIRUSES

Stay ahead of the curve with the latest updates from the CDC and ACP on COVID-19 vaccinations and outpatient treatments, designed to prepare healthcare settings for the upcoming fall and winter season.

Learn how the termination of USAID’s DEEP VZN program could signal a shift in global health priorities, emphasizing the importance of disease surveillance and biosecurity over speculative virus hunting.

New research suggests that a significant portion of patients with post-viral syndrome may have been exposed to SARS-CoV-2, raising questions about their exclusion from long COVID clinics and research. Learn more about the implications for patient care and research inclusion criteria.

Pharmacists, learn more about nirsevimab and how you can help to protect infants from RSV, the leading cause of hospitalization in infants under the age of 1.

The ACIP’s recent recommendations on RSV vaccines for adults aged 60 and above emphasize shared clinical decision-making. Ensure you’re informed to best guide your patients’ choices.

The FDA’s approval of Beyfortus offers a promising tool for RSV disease prevention in neonates and young children. This novel intervention, underscored by robust clinical trial data, marks a crucial stride towards protecting infant health in the US.